"It’s not just the idea, it’s knowing what to do with it"

In Amanda Stark’s world of biotechnology and pharmaceuticals it’s becoming increasingly difficult for her clients to capitalise their work. “You can’t just patent genes anymore, so it’s become even more important to be strategic about exactly what you patent and why.”

Amanda started her career in the UK as an IP manager in a biotech start-up. She qualified as a UK patent agent and a European Patent Attorney and worked in private practice firms in the UK for 10 years before moving to Griffith Hack in 2003. Whether her client is a small research institution, or a large multi-national, Amanda picks up the technology quickly and cuts through to the critical issues required for effective commercialisation. She gets into her clients’ business and guides them, helping them to make the most of their IP. 

Amanda is often called on to provide due diligence, IPO and licensing advice. She has particular experience in human and animal health and plant biotechnology.  She lectures in Australia and overseas on issues around biologics and biosimilars as well as patent strategy.  

An example of Amanda’s strategy in action involves a recent patent term extension application, where her work resulted in a ground breaking decision which extended the term of a patent for a process for making a product comprising a recombinant molecule. 

“It’s about finding the right path to take. There are many options and the choices you make early on have important consequences later. It’s all about strategy.”


  • Post graduate research (Protein Crystallography) - Glasgow University, UK
  • Bachelor of Science (Biochemistry) (Honours) - University of Bristol, UK
  • Certificate in Intellectual Property - University of London, UK
  • Registered Patent Attorney (Australia and New Zealand)
  • Registered Patent Attorney (United Kingdom)(CPA)
  • Qualified Patent Attorney (European)


  • 2021

    Recognised WIPR Leader

    WIPR Leaders